{"name":"Follicle Pharma Ltd","slug":"follicle-pharma-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOSEdGcm1naUVOWFNpc0dwSmJBUmY5WnR1aE1rVE5xNkZfNEFjTTFIdmxTNW1XTjA3YnduQzFTSkZpSlNRLVZIY3VpUXJxeFFrMldFcE1CSU9fWC1mZWVWejlIZngxSzlwQXhRaU5iaElCZHFPaE5JbEpmTWlGcGJjU2p3X1VmMjJjNXRDVEJmS05oOGVxN3p3?oc=5","date":"2026-03-18","type":"pipeline","source":"Yahoo Finance","summary":"Pelage Pharmaceuticals’ PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026 - Yahoo Finance","headline":"Pelage Pharmaceuticals’ PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Derma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOUzRsamZGMVd5blFJaF9jN2xUUU9nem56Y2lGendtdzR5N1llMFRzR29XMDMwVHNiUWpqM19zbEpEajAtalk1dHZSSE5LZmFOZ2hYQzBGOWdrWmFKZDdVUEM2SU00WHYySTYwRFVTd1FZeEhLSTBDYzdwb0RiTkprMjJMVHQ?oc=5","date":"2026-01-27","type":"pipeline","source":"Drug Discovery News","summary":"Can hair loss be the next GLP-1 moment? - Drug Discovery News","headline":"Can hair loss be the next GLP-1 moment?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQSGlMVV9KNV9YTVU4TlhfZEpmSG5LQ2wxZ3U4MTh6dFRfamtnOXkybUhib2hROWRkcFdsdXh0S3FaS2VRNEJtN2UtazFpMXdvaVhSWU1TcG5BVmtuM0ZTVjYxOG8tZ2hWekl6aGZTczJBYUV2ckxMWExSbnlKVmZJYXdNQmJOV0JpYUVsYUJPVmdUel9kcTNCdFNJV3dGM25Jdkdz?oc=5","date":"2025-12-24","type":"regulatory","source":"pharmacytimes.com","summary":"FDA Approves 1-Minute SC Mosunetuzumab for R/R Follicular Lymphoma - pharmacytimes.com","headline":"FDA Approves 1-Minute SC Mosunetuzumab for R/R Follicular Lymphoma","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE9YMjNkNFcxV2pOcTdhSkp6aXVnMGlhTFI0RjZxZUhCODI3RWZIWDN3MVYzaE5IbHdKQ05xcUdyRFdVcUtpNy1KVjNfaTRZN0ZvY1lNQlFvTVVPdE1sTTRDRDR3ZzJOWnhvZTBXUnR3SQ?oc=5","date":"2025-12-18","type":"regulatory","source":"Pharmaceutical Technology","summary":"EC approves Incyte’s Minjuvi combo for follicular lymphoma - Pharmaceutical Technology","headline":"EC approves Incyte’s Minjuvi combo for follicular lymphoma","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQYjJ3ZUdrRUp2VmFpSEJuYUd6WDBPellNNTduVzI0NEpaUTNOMWdtOVVESTlTdWt6M3ZLY09xalY2TGxXNGdQenRHRmxuNWdNVGpHWkh6Z1FrcVJyZVBVRTdfSGljYXNBWTlWeE9uLVNFRTN2ckFLVjgwZE1GODlBRm5qdXFrSGNXVlFUU0djME5pUkZiVjgza1ZUQjhtS1NQR014bFR0VW9WQlYxelpFcVRJcDRHbUNk?oc=5","date":"2025-10-17","type":"trial","source":"BioXconomy","summary":"$120m Series B drives Pelage's hair follicle stem cell therapy toward Phase III - BioXconomy","headline":"$120m Series B drives Pelage's hair follicle stem cell therapy toward Phase III","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxON0s3Um5USm5yd1F1NC1hWGptMFhtQ0ZaTEFkLWNqbzZUMlVlY0JBLW1OLVFyUGJiVWxqSEZJbDQzeloydkRrdTBkRWhTclZ3NkhMcmp6ZnFkWnh5MU11TTNZb20xX0tyNzh5S3N0RmtmWi1WcUY5ejZhOEEtXzhEMVRxQ3d4Zi1BenItNHpQQVgxelZQZ3NOeHB2dk81cU9qQ2daRw?oc=5","date":"2025-10-16","type":"regulatory","source":"PharmaTimes","summary":"FDA grants fast Track status to Enterome’s EO2463 for follicular lymphoma - PharmaTimes","headline":"FDA grants fast Track status to Enterome’s EO2463 for follicular lymphoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQaWVuMUpiTDNfYXVaOUJYdk5UWGx3aENhVWpqcTV5RThxd3JaSk1JN3ZjRDI5dVZldFBreWhDOHJhbU9za2xEOEtvaER2N255UlJzc09PcGNEb2ZyRmk5UUZ2dDhBX3hNYXFLdVJrbDZSc1dDUGgwTTQ2LURhekpBMnBkS2ZYNDVzQTVFd29sS0YzcUdYZXJwTmNZanA4RGJh?oc=5","date":"2025-10-15","type":"pipeline","source":"BioPharma Dive","summary":"A regenerative therapy for hair loss attracts a mega-fundraising round - BioPharma Dive","headline":"A regenerative therapy for hair loss attracts a mega-fundraising round","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQWk91UjhnRmNhVC02NkNkRGFaUHQwNDdqbGhGRHJFbUt0cDJCQnhpNm1fZWxka2xVRERvTGFTNzdqeTNsUF92Nkg3NzkwdWtrZlpZX24tSnlBV2I5aGhTWjdKVmF4T04temFaV04xQ0NnZkhCbmd0dVV2UXlSV1pqWUs4TkozR0FjSE9lTlI1RkJaQnRMeU9FOGhEUkNybVBTdXlSdUcxS1NzS1RieXYwYTl2SGVTeU5Ha1JISA?oc=5","date":"2025-10-15","type":"pipeline","source":"fiercebiotech.com","summary":"Pelage Pharma raises $120M series B to untangle roots of hair loss with regenerative med - fiercebiotech.com","headline":"Pelage Pharma raises $120M series B to untangle roots of hair loss with regenerative med","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQaTdFQ01iaGFfYjB4RERpcFp1TnZPOUNZS05wLUJWbklLUHJqMXBiZE93REx6WUZMOTdfeWFLRmlwUjJSY1pzRDVyWUVocE41VzZvbENpTWNCcTJmenVka2FuT0NBOUE0YU81aFFTS1ZTY0ZsZm5iclhqbzBvMHpZQ2xUU2tVcURVRzJYaEYtcHc?oc=5","date":"2025-10-09","type":"pipeline","source":"Time Magazine","summary":"Pelage Pharmaceuticals PP405: The Best Inventions of 2025 - Time Magazine","headline":"Pelage Pharmaceuticals PP405: The Best Inventions of 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNbjNLdENSanM0UF95WlQwSFJQTE9VQ000alNYRTF3Vm9jSHpSUEtOVTcxNXRMYzdlSkNWQ2w4N0h1c2dfZDBQaW9ZOGIwT09NdkVxUUMtckFCbXFzMUdLdGRnUzIxc0tDS0J0Z0NLOHhSTlpZZzZWQTg2YURPc1UzY0YtNWphQ3Z4YktkcXNGcnYweS1BV3RSZEdOaUtMbXkxUFd6U9IBqgFBVV95cUxQTkRaakhIcVFoQ1hVSGFTSVNyTWdBVmNUelhnaXJZamFSMXdQSmhseEI1aXhhWmVULXYxNXFNbTJadXJxTmMweWZsMUE1UTFzdXA3djd4STFBRVJLa3lfcTFwQ0JXLWJJMkFkemNLa1RMZWI3bmVLcG1BNW04M3diaU0xNldXTlNFaVlXa3piNFRRdGZmQXpXLXZ6Yk9rSFhEUmQ5OXZ2Mi0tdw?oc=5","date":"2025-09-09","type":"pipeline","source":"Business Standard","summary":"Could this be the end of baldness? Scientists test breakthrough hair drug - Business Standard","headline":"Could this be the end of baldness? Scientists test breakthrough hair drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxNdnI0cDVOQXhabmpzSm5pcWpDZWRQOXB0RHlra0RuTHlGNkx4NnY0NjBIZ1VpVnduMmEzUzN6T2ZZaXJWRzU2N04tTGJLbEdCZzNGZ3paUkdYdF82cUxpcFRHZ3RVTS15Z3FQbXR5RjRiT25kSEtvVl8yVHM5dDh5bThmbjZSUF96cldKOHBRc3hFQTdPanBHR0Z2Z21TcUtJVzVVOWJ4azRJYWdNblA2UThCWjNTSzJuemlldzQ3dl9LcWVFQ0xzOFRiaEN6dThtX1dvaDFxbWd2OVhvcXNZT3dqblI3ODQtNnJqM3VB?oc=5","date":"2025-06-17","type":"trial","source":"BioSpace","summary":"Pelage Pharmaceuticals Announces Positive Phase 2a Clinical Trial Results for PP405 in Regenerative Hair Loss Therapy - BioSpace","headline":"Pelage Pharmaceuticals Announces Positive Phase 2a Clinical Trial Results for PP405 in Regenerative Hair Loss Therapy","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxNOGo2bG1sOUh6emRZUWVvRFZtT3NmWHFkUlB6RzluMFpfMXFjd1IzQlVwbG53TUtUd2ZnUGFHSlRFZ2R2VXg5ck1ZbTJtUnhBdkhXM28yTVlrRG9FOEkwQUhpaE8tMExPdmlMc182SWoxYVlFXzdRSlVyV2haV0c4QXpGZmIycUozbEZFUG1pUUdtSmVPUDhObVR4V2pCQ1RHSHVSeUhIRjVQbnNmQW1tN2dLQkxFR20zQ2ZuX3M0LXhPdnlzblFWUVBLcVFOOGo5ZkJibGtDN2RLMy1WZ2djQV9nQnRyY3hidmZSZmhvdk1CMkp2QUlsSmN2TnZ3WGRxSEQyVkJ1REFGU1ZrRUlNS0FneFJrWEUxY3RoRUFuQkZTQTFiSkZPQ2lUeUVZeHJENll2bmgtRQ?oc=5","date":"2025-06-04","type":"pipeline","source":"prnewswire.com","summary":"Follicular Lymphoma Market Growth Accelerates at a CAGR of 6% During the Forecast Period (2025-2034) Due to the Advancements in Targeted Therapies | DelveInsight - prnewswire.com","headline":"Follicular Lymphoma Market Growth Accelerates at a CAGR of 6% During the Forecast Period (2025-2034) Due to the Advancem","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}